查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2028 年亞太地區可流動止血劑市場預測 - 區域分析 - 按材料、產品、應用和最終用戶
市場調查報告書
商品編碼
1494344

到 2028 年亞太地區可流動止血劑市場預測 - 區域分析 - 按材料、產品、應用和最終用戶

Asia Pacific Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 138 Pages | 訂單完成後即時交付

價格

亞太地區可流動止血劑市場預計將從2022年的1.7664億美元成長到2028年的2.7519億美元。

醫院和手術中心數量的增加推動了亞太地區可流動止血劑市場

傷害仍然是公眾健康的重大問題。全球創傷和事故病例的增加是亞太地區可流動止血劑市場的主要驅動力。根據世界衛生組織 (WHO) 統計，每年約有 130 萬人因道路交通事故而縮短生命。 20 至 5000 萬人遭受非致命傷害，其中許多人因受傷而殘疾。在全球範圍內，超過三分之一的院前死亡和超過 40% 的 24 小時內死亡是由出血或失血過多造成的。由於與運動、職業傷害和年齡相關的功能障礙相關的肌肉骨骼疾病的增加，手術數量不斷增加。然而，由於運動相關的傷害，很大一部分健康收益被損失了。美國國家醫學圖書館報告指出，與其他國家相比，中國患有創傷性腦損傷 (TBI) 的患者基數較大，這使得這種情況成為主要的公共衛生問題。因此，不斷增加的傷害和外科手術導致了流動止血劑的大量採用，從而推動了預測期內市場的成長。

亞太地區可流動止血劑市場概況

亞太地區流動止血劑市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。亞太地區預計將成為所有其他地區中成長最快的地區。由於對醫療保健行業基礎設施發展的投資、外科手術數量的增加、對提供卓越手術結果的日益重視以及有利的監管批准，亞太地區的市場成長預計將以更快的速度成長。中國在亞太地區流動止血劑市場中佔有相當大的佔有率。由於人們越來越重視提供優質的外科護理，以及對現代醫療器材的需求不斷成長，預計該市場將會成長。出血性疾病盛行率的上升為可流動止血劑的設計、開發和試驗鋪平了道路。根據中國血友病治療中心協作網路（HTCCNC）的研究，2007年至2019年，HTCCNC共識別出17,779名A型血友病患者。的血友病家族史。在實驗室測量的疾病嚴重程度的患者中(N = 13,116)，6,519 名患者患有重度HA (49.7%)，4,788 名患者患有中度HA (36.5%)，1,809 名患者患有輕度HA (13.8%)。因此，在預測期內，血友病發生率的上升將增加對可流動止血劑的需求。

亞太地區可流動止血劑市場收入及 2028 年預測（百萬美元）

亞太地區流動止血劑市場區隔

亞太地區可流動止血劑市場分為材料、產品、應用、最終用戶和國家。

根據材料，亞太地區流動止血劑市場分為牛明膠和豬明膠。 2022 年，牛明膠細分市場在亞太地區可流動止血劑市場中佔據更大佔有率。

從產品角度來看，亞太地區可流動止血器市場分為組合止血器、被動式止血器和主動式止血器。 2022 年，組合止血劑細分市場在亞太地區可流動止血劑市場中佔據最大佔有率。

根據應用，亞太地區可流動止血劑市場分為一般外科、心臟外科、血管外科、骨科外科、神經和脊椎外科等。 2022 年，一般外科細分市場在亞太地區可流動止血劑市場中佔最大佔有率。

根據最終用戶，亞太地區可流動止血劑市場分為醫院和診所、門診手術中心等。 2022 年，醫院和診所領域在亞太地區流動止血劑市場中佔據最大佔有率。

依國家/地區分類，亞太地區流動止血劑市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。 2022年，中國將主導亞太地區流動止血劑市場。

Baxter International Inc、Ethicon (Johnson & Johnson)、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology 和 Aegis Lifesciences 是亞太流動止血劑市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區可流動止血劑市場 - 市場格局

  • 概述
    • 亞太地區 PEST 分析
  • 亞太地區專家意見

第 5 章：亞太地區可流動止血劑市場 - 主要市場動態

  • 市場促進因素
    • 受傷和手術數量不斷增加
    • 老年人口增加
  • 市場限制
    • 熟練專業人員短缺和報銷政策不佳
  • 市場機會
    • 醫院和手術中心數量不斷增加
  • 未來的趨勢
    • 導致產品創新的研發 (R&D) 活動
  • 影響分析

第 6 章：可流動止血劑市場 - 亞太地區分析

  • 亞太地區可流動止血劑市場收入預測與分析
    • 亞太地區可流動止血劑市場收入預測與分析

第 7 章：亞太地區可流動止血器市場分析 - 依材料

  • 2021 年及 2028 年亞太地區可流動止血劑市佔率（依材料）（%）
  • 牛明膠
  • 豬明膠

第 8 章：亞太地區可流動止血劑市場 - 按產品

  • 概述
  • 2021 年及 2028 年亞太地區可流動止血劑市佔率（按產品）（%）
  • 組合止血鉗
    • 概述
    • 組合止血器：亞太地區可流動止血器市場 - 收入與 2028 年預測
  • 被動止血器
    • 概述
    • 被動止血器：亞太地區可流動止血器市場 - 收入和 2028 年預測
  • 主動止血器
    • 概述
    • 主動止血器：亞太地區可流動止血器市場 - 收入與 2028 年預測

第 9 章：亞太地區可流動止血劑市場 - 按應用

  • 概述
  • 2021 年及 2028 年亞太地區可流動止血劑市佔率（按應用分類）（%）
  • 一般外科
    • 概述
    • 一般外科：亞太地區可流動止血劑市場 - 收入和 2028 年預測
  • 心臟外科
    • 概述
    • 心臟手術：亞太地區可流動止血劑市場 - 收入和 2028 年預測
  • 血管外科
    • 概述
    • 血管外科：亞太地區可流動止血劑市場 - 收入和 2028 年預測
  • 骨科手術
    • 概述
    • 骨科手術：亞太地區可流動止血劑市場 - 收入和 2028 年預測
  • 神經和脊椎外科
    • 概述
    • 神經和脊椎外科：亞太地區可流動止血劑市場 - 收入和 2028 年預測
  • 其他
    • 概述
    • 其他：亞太地區可流動止血劑市場 - 收入和 2028 年預測

第 10 章：亞太地區可流動止血器市場分析 - 按最終用戶

  • 概述
  • 2021 年及 2028 年亞太地區可流動止血器市場佔有率（依最終使用者）（%）
  • 醫院和診所
  • 門診手術中心
  • 其他

第 11 章：亞太地區可流動止血器市場收入和 2028 年預測 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區

第 12 章：可流動止血劑市場-產業格局

  • 概述
  • 可流動止血劑市場的成長策略（%）
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 13 章：公司簡介

  • Baxter International Inc
  • Ethicon (Johnson & Johnson)
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Aegis Lifesciences

第 14 章：附錄

Product Code: BMIRE00029829

The Asia Pacific flowable hemostats market is expected to grow from US$ 176.64 million in 2022 to US$ 275.19 million by 2028. It is estimated record a CAGR of 7.7% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuels Asia Pacific Flowable Hemostats Market

Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the Asia Pacific flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. The National Library of Medicine report states China as a large base of patients agonizing traumatic brain injury (TBI) compared to other countries, making this condition a major public health concern. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market's growth during the forecast period.

Asia Pacific Flowable Hemostats Market Overview

The Asia Pacific flowable hemostats market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of market in the Asia Pacific region is expected to grow at a faster pace owing to investments made in the infrastructure development of the healthcare sector, rising number of surgical procedures, growing emphasis on providing superior surgical outcomes, and favorable regulatory approvals. China holds a considerable share in the Asia Pacific flowable hemostats market. The market is expected to grow owing to the growing emphasis on providing superior surgical care, and the growing demand for modern healthcare instruments. The rise in the prevalence of bleeding disorders has paved the way for the design, development, and piloting of flowable hemostats. According to a Hemophilia Treatment Center Collaboration Network of China (HTCCNC) study, HTCCNC identified 17,779 patients with Hemophilia A from 2007 to 2019. Patients were predominantly male (99.99%), and 28.3% had a known family history of hemophilia. Among patients with lab-measured disease severity (N = 13,116), 6,519 had severe HA (49.7%), 4,788 had moderate HA (36.5%), and 1,809 had mild HA (13.8%). Thus, rising incidences of hemophilia will increase the demand for flowable hemostats during the forecast period.

Asia Pacific Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Flowable Hemostats Market Segmentation

The Asia Pacific flowable hemostats market is segmented into material , product, application, end user, and country .

Based on material, the Asia Pacific flowable hemostats market is bifurcated into bovine gelatin and porcine gelatin. The bovine gelatin segment held a larger share of the Asia Pacific flowable hemostats market in 2022.

In terms of product , the Asia Pacific flowable hemostats market is segmented into combination hemostats , passive hemostats, and active hemostats . The combination hemostats segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on application , the Asia Pacific flowable hemostats market is categorized into general surgery , cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others . The general surgery segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on end user , the Asia Pacific flowable hemostats market is segmented into hospitals and clinics , ambulatory surgery centers, and others . The hospitals and clinics segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

By country, the Asia Pacific flowable hemostats market is categorized int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the Asia Pacific flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Flowable Hemostats Market - By Material
    • 1.3.2 Asia Pacific Flowable Hemostats Market - By Product
    • 1.3.3 Asia Pacific Flowable Hemostats Market - By Application
    • 1.3.4 Asia Pacific Flowable Hemostats Market - By End User
    • 1.3.5 Asia Pacific Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 Asia Pacific PEST Analysis
  • 4.2 Asia Pacific Experts Opinion

5. Asia Pacific Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis
    • 6.1.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis

7. Asia Pacific Flowable Hemostats Market Analysis - By Material

  • 7.1 Asia Pacific Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
  • 7.2 Bovine Gelatin
    • 7.2.1 Overview
    • 7.2.2 Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Porcine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • 8.3 Combination Hemostat
    • 8.3.1 Overview
    • 8.3.2 Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Passive Hemostat
    • 8.4.1 Overview
    • 8.4.2 Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Active Hemostat
    • 8.5.1 Overview
    • 8.5.2 Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • 9.3 General Surgery
    • 9.3.1 Overview
    • 9.3.2 General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Cardiac Surgery
    • 9.4.1 Overview
    • 9.4.2 Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Vascular Surgery
    • 9.5.1 Overview
    • 9.5.2 Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Orthopedic Surgery
    • 9.6.1 Overview
    • 9.6.2 Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Neuro and Spine Surgery
    • 9.7.1 Overview
    • 9.7.2 Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 Asia Pacific Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgery Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 Asia Pacific: Flowable Hemostats Market
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
      • 11.1.2.1 China: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.1 China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.1.2 China: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.3 China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.4 China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.5 China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.2 Japan: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.1 Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.2.2 Japan: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.3 Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.4 Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.5 Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.3 India: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.1 India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.3.2 India: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.3 India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.4 India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.5 India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.4 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.1 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.2 South Korea: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.3 South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.4 South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.5 South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.5 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.1 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.2 Australia: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.3 Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.4 Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.5 Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.6 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.1 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.2 Rest of Asia Pacific: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.3 Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.4 Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.5 Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Flowable Hemostats Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Aegis Lifesciences
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Asia Pacific Glossary of Terms

List Of Tables

  • Table 1. China: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Japan: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. India: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. South Korea: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 14. South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 15. South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 16. South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Australia: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 19. Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 20. Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 21. Rest of Asia Pacific: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 22. Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 23. Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 24. Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Organic Developments in the Flowable Hemostats Market
  • Table 26. Inorganic Developments in the Flowable Hemostats Market
  • Table 27. Asia Pacific Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Flowable Hemostats Market Segmentation
  • Figure 2. Asia Pacific Flowable Hemostats Market, By Country
  • Figure 3. Asia Pacific Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in Asia Pacific Flowable Hemostats Market
  • Figure 5. Asia Pacific Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. Asia Pacific Flowable Hemostats Market, Market Attractiveness
  • Figure 7. Asia Pacific: PEST Analysis
  • Figure 8. Asia Pacific Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. Asia Pacific Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. Asia Pacific Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Asia Pacific Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Asia Pacific Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 30. Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
  • Figure 31. China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 32. Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 33. India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 34. South Korea: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 35. Australia: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 36. Rest of Asia Pacific: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 37. Growth Strategies in the Flowable Hemostats Market (%)